Brandon Tom, President and Chief Executive OfficerWhen his case reached Orsini, the team acted immediately, coordinating with the prescriber, family, payor, and manufacturer. Approvals were secured in record time, and the therapy was dispensed the day before his birthday, making him one of the first commercial patients in the U.S. to receive it.
For Orsini, moments like these define the company’s purpose: speed, precision, and compassion when it matters most.
Founded in 1987, Orsini has grown in recent years into a critical partner across the cell and gene therapy (CGT) ecosystem. The company’s approach is rooted in collaboration with patients, providers, biopharmaceutical innovators, and payors who share a common goal: to ensure that life-changing therapies reach the people who need them.
At the heart of every process lies Orsini’s enduring promise: No Patient Left Behind. Every patient story at Orsini is personal. Blending precision with empathy, the company has guided over 6,800 patients and countless families, providers, and biopharma partners through the intricate pathways of cell and gene therapy, ensuring that care is as compassionate as it is exacting.
Orsini provides the operational backbone for biopharmaceutical partners, turning therapy launches into coordinated successes. It delivers a streamlined pathway for healthcare providers by aiding with the benefit verification, reimbursement, and patient education processes. And for patients and families, it offers a steady hand—someone who understands that behind every form, signature, and vial is a life waiting for change.
-
Our mission has always been simple yet deeply personal—to make sure no patient is left behind. We deliver therapies with hope, access, and certainty when it matters most.
The Centralized Hub of Excellence
Orsini entered the gene therapy space in 2017 and has since supported 11 CGT programs in hematology, neurology, and ophthalmology. These years of experience have helped shape the company’s dedicated Cell and Gene Therapy Center of Excellence, a single point of contact for patients, providers, and manufacturers.
Every aspect of the therapy journey—benefit verification, reimbursement support, scheduling, dispensing, and follow-up—flows through this centralized hub. Dedicated phone, fax, and email lines keep communication consistent and straightforward for all parties involved.
Gene therapies are among the most complex treatments in medicine. They are costly, highly individualized, and time-sensitive. Orsini’s infrastructure and trained specialists are built to move at the speed these therapies demand.
“When a time-critical prescription arrives, it’s all hands on deck,” says Brandon Tom, president and CEO. “Our team coordinates every moving piece so the therapy reaches the patient without delay.”
Accelerating Therapy Delivery
Beyond speed, Orsini’s differentiator lies in its access and coverage expertise. The company is adept at navigating dual-benefit contracting across pharmacy and medical benefits. It has deep experience managing Letter of Agreement (LOA) negotiations, requirements that often determine whether a patient can receive treatment. As the leading independent specialty pharmacy in cell and gene therapy, Orsini has been able to unlock strategic conversations with payors to ensure faster access to therapy for patients. This operational fluency helps remove administrative barriers that could otherwise stall therapy delivery.
Handling the products themselves requires equal precision. Orsini’s facilities are equipped for cold-chain and cryogenic management across all temperature ranges, using validated pharmaceutical-grade freezers and processes such as dry-ice handling and cryogenic labeling. These safeguards protect product integrity and meet manufacturer specifications, ensuring that each dose arrives in perfect condition.
As the number of approved cell and gene therapies continues to grow, Orsini’s forward-looking infrastructure ensures that innovation in the lab translates into access in the real world.
Gene Therapy Launches Depend on More Than Approval
Getting a gene therapy approved is only part of the challenge. The harder test often begins afterward, when manufacturers, providers, payors and families all have to move through a process that leaves very little room for delay. A missed authorization step, unclear reimbursement pathway or breakdown in communication can slow treatment at the exact moment patients are racing against disease progression or eligibility timelines.
That is why pharmacy partners have taken on a much larger role in gene therapy launches.
These therapies are expensive, medically complex and highly time sensitive. Biotech companies are no longer looking for a pharmacy that simply dispenses a product. They need a partner that can keep access moving when insurance requirements become complicated, documentation is incomplete or benefit structures overlap between pharmacy and medical coverage. In many cases, the pharmacy partner becomes the operational center holding the process together.
The challenge is coordination. Manufacturers of gene therapies, the prescribers, specialty pharmacies, payors, hospitals and patients' families are all working on separate timelines. As communication breaks down between these disparate entities, delays begin to pile up at an alarming rate. Manufacturers launching therapies want the providers of their therapies to offer transparency into the status of each case, the obstacle delaying it, and the person accountable for moving the case to the next step. Without structure like that, access issues can quietly arise and compound until the appropriate time window for treatment can no longer be reclaimed.
Timing is of greater importance in gene therapy than it is for many standard specialty drug categories. Some patients are operating under age limitations; some will eventually lose ground in the course of their disease to the window for treatment; even a logistical delay can have a clinical impact. This kind of pressure means that responsiveness means something different; it means the extent to which a company can quickly assemble families, providers, and payers so that the care plan doesn't fall apart.
There is also the product-handling side, which carries its own level of complexity. Many cell and gene therapies require ultra-cold storage, cryogenic handling, strict chain-of-custody controls and highly specific shipping conditions. Those are not operational details companies can afford to treat casually. If handling breaks down, patient access breaks down with it. Providers need confidence that products will arrive correctly managed and ready for use without constant follow-up calls or fragmented updates.
Rare disease experience matters here too. Families navigating gene therapy are often already dealing with exhausting care journeys before treatment even begins. Pharmacy teams that understand how to support those patients while still managing reimbursement pressure and logistical complexity tend to become much more valuable to manufacturers over time.
Orsini has built its gene therapy pharmacy model around those realities. Its Cell and Gene Therapy Center of Excellence has been operating since 2017, supporting benefit verification, reimbursement coordination and therapy access across multiple programs. The company also brings experience with dual-benefit contracting, letter-of-agreement negotiations, ultra-cold and cryogenic product handling and broader rare disease pharmacy support. For biotechnology companies trying to move patients from approval to treatment without losing momentum along the way, that operational coordination has become increasingly important.
...Read more
Gene Therapy Pharmacy Solution Info
Q1
What distinguishes Orsini Specialty Pharmacy among Top Gene Therapy Pharmacy Solutions providers?
Orsini Specialty Pharmacy has earned recognition among Top Gene Therapy Pharmacy Solutions providers through its highly coordinated approach to specialty pharmacy services, patient support and complex therapy management. The company specializes in handling rare disease and advanced therapeutic treatments that require precise logistics, payer coordination and individualized patient care. Its integrated service model combines pharmacy expertise, reimbursement support and therapy navigation to help patients access specialized treatments more efficiently. Orsini Specialty Pharmacy also differentiates itself through dedicated clinical support teams that remain closely involved throughout the treatment journey. (lifesciencesreview.com )
Q2
How does Orsini Specialty Pharmacy approach gene therapy support?
Patient-centered care coordination forms the foundation of the company’s service strategy. Unlike many Gene Therapy Pharmacy Solutions providers that focus only on medication dispensing, Orsini Specialty Pharmacy supports patients and healthcare organizations across broader therapy management functions including benefits verification, prior authorization support, financial assistance coordination and treatment education. Its pharmacy teams manage the complex handling requirements associated with advanced therapies while helping maintain continuity of care during treatment initiation and follow-up. The company also emphasizes personalized communication designed to improve patient confidence and treatment adherence. (lifesciencesreview.com )
Q3
Why is Orsini Specialty Pharmacy relevant to the growing gene therapy landscape?
Advanced therapies and rare disease treatments continue to reshape healthcare delivery, creating increased demand for specialized pharmacy infrastructure and patient support services. Orsini Specialty Pharmacy addresses these challenges through Gene Therapy Pharmacy Solutions designed to simplify access, improve care coordination and support complex treatment pathways. Its expertise in specialty pharmacy management helps healthcare providers and patients navigate reimbursement requirements, therapy logistics and ongoing clinical coordination more effectively. The company’s ability to support highly specialized treatments also strengthens its relevance within rapidly evolving precision medicine and rare disease markets. (lifesciencesreview.com )
Q4
What role does care coordination play at Orsini Specialty Pharmacy?
Comprehensive care coordination remains central to Orsini Specialty Pharmacy’s service model. The company works closely with physicians, healthcare organizations and patients to manage the administrative and clinical complexities associated with specialty therapies. Its teams coordinate medication delivery, monitor treatment progress and provide ongoing therapy education tailored to individual patient needs. Gene Therapy Pharmacy Solutions providers often differentiate themselves through patient engagement and logistical precision, and Orsini Specialty Pharmacy reinforces that distinction through its high-touch support structure and specialized therapy management expertise. (lifesciencesreview.com )
Q5
How does Orsini Specialty Pharmacy support patients during treatment?
Dedicated patient advocacy plays an important role in the company’s support philosophy. Orsini Specialty Pharmacy helps patients navigate financial assistance programs, insurance approvals and treatment scheduling while maintaining direct communication throughout therapy administration and follow-up care. Its clinical and pharmacy teams provide education and personalized guidance designed to reduce treatment-related uncertainty and improve access to specialized therapies. Among Gene Therapy Pharmacy Solutions providers, the company stands out for its individualized patient engagement and long-term support approach tailored to complex and rare disease treatments. (lifesciencesreview.com )
Q6
Why has Orsini Specialty Pharmacy gained recognition in specialty pharmacy services?
Industry recognition for Orsini Specialty Pharmacy reflects its commitment to patient-focused specialty pharmacy care and advanced therapy support. The company has strengthened its reputation through its ability to coordinate complex treatment pathways involving rare diseases, gene therapies and specialty medications requiring high levels of clinical oversight. Its integrated support structure, reimbursement expertise and patient advocacy services continue to improve treatment accessibility and continuity of care. This combination of specialty pharmacy expertise, coordinated patient support and advanced therapy management reinforces Orsini Specialty Pharmacy’s standing within Gene Therapy Pharmacy Solutions. (lifesciencesreview.com )
